Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6671-6680 of 13615

Page
per page
  1. H-Leu-Gly-OH
    BA9386 H-Leu-Gly-OH
    Summary: A glycine derivative.
  2. Fatostatin
    A9954 Fatostatin
    Summary: A specific inhibitor of SREBP
      ≥25.35 mg/mL
  3. BAY-707
    BA4013 BAY-707
    Summary: BAY-707 is a substrate-competitive, highly efficient and selective inhibitor.
  4. NX-2127
    BA8820 NX-2127
    Summary: NX-2127 is an orally effective inhibitor that induces the degradation of mutations in cells.
  5. FR122047 (hydrate)
    C5551 FR122047 (hydrate)
    Summary: selective inhibitor of COX-1
      ≤1 mg/mL
  6. Coumestrol
    C5832 Coumestrol
     1 Citation
    Summary: competitive binder of the estrogen receptors ERα
      ≥12.35 mg/mL
  7. Cy7 NHS ester (non-sulfonated)
    A8104 Cy7 NHS ester (non-sulfonated)
     1 Citation
    Summary: Cy7 NHS ester (non-sulfonated, tetrafluoroborate), labels primary amines, near-infrared fluorescence.
      ≥34.1 mg/mL
  8. KKL-35
    B8498 KKL-35
    Summary: Trans-translation tagging reaction inhibitor
      ≥16.3 mg/mL
  9. Barnidipine (hydrochloride)
    C3727 Barnidipine (hydrochloride)
    Summary: calcium-channel blocker
      insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL
  10. VU590 (hydrochloride)
    C4778 VU590 (hydrochloride)
    Summary: inhibitor of KCNJ1
      ≤20 mg/mL

Items 6671-6680 of 13615

Page
per page